MoreTrials

MoreTrials: A public campaign to make it much easier to do randomised trials

You are here: Home / News Post / The German Network for Evidence-based Medicine (DNEbM) endorses MoreTrials

Oct 06 2016

The German Network for Evidence-based Medicine (DNEbM) endorses MoreTrials

German EBM Network

 

 

 

Treatment decisions should be based upon reliable evidence from randomised trials. To achieve this all trials are first registered and then the results are reported. This has been the main focus of EbM in recent years. Much progress has been made on prospective registration. The case has been made for making the results available at the end of a trial, but much more work is still required to make this work in practice. Any solution needs to be considered in terms of its impact on the whole trial ecosystem, rather than whether it just promotes some vague concept like “data sharing.”

The real paradox in medicine is the simple fact that at the same time that there has been increasing recognition of the need for reliable evidence from randomised trials it has also become much more difficult and costly to do trials. EbM is now increasingly turning its attention to removing these barriers to doing randomised trials in order to make it much easier to do trials.

Here is an example of this.

The German Network for Evidence-based Medicine was founded in 2000 and now has over 850 members. You can read its news item supporting MoreTrials here. It is a member of the Association of the Scientific Medical Societies in Germany (AWMF), which was an early and proactive supporter of MoreTrials.

I am very much looking forward to speaking to the AWMF at their meeting in November and it is great to see the growing support for MoreTrials throughout Germany.

 

Print Friendly

Written by tim sprosen · Categorized: News Post

Search Form

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

A public campaign for more, better, randomised trials

Pages

  • The Problem
    • ICH
    • ICH-GCP guideline
    • Response from EMA/ICH
    • Stories to Highlight the Problems
  • The Solution
    • Developing the New-GCP
    • The Plan
  • News
  • The unique value of randomised trials
    • Illustration
    • The wider context
    • CTTI: Making things better
    • Stories of Trials That Matter
  • Have your say
  • Supporters
    • AllTrials
  • Join us
  • Contact us

Join

Search Form

  • 
  • 

© 2016 Moretrials.net · Rainmaker Platform